Fanomezana M. Ranaivoson
Sventja von Daake1,2
Davide Comoletti- 1Child Health Institute of New Jersey, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
- 2Department of Neuroscience and Cell Biology, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
- 3Department of Pediatrics, Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ, USA
Reelin is a neuronal glycoprotein secreted by the Cajal-Retzius cells in marginal regions of the cerebral cortex and the hippocampus where it plays important roles in the control of neuronal migration and the formation of cellular layers during brain development. This 3461 residue-long protein is composed of a signal peptide, an F-spondin-like domain, eight Reelin repeats (RR1–8), and a positively charged sequence at the C-terminus. Biochemical data indicate that the central region of Reelin binds to the low-density lipoprotein receptors apolipoprotein E receptor 2 (ApoER2) and the very-low-density lipoprotein receptor (VLDLR), leading to the phosphorylation of the intracellular adaptor protein Dab1. After secretion, Reelin is rapidly degraded in three major fragments, but the functional significance of this degradation is poorly understood. Probably due to its large mass and the complexity of its architecture, the high-resolution, three-dimensional structure of Reelin has never been determined. However, the crystal structures of some of the RRs have been solved, providing important insights into their fold and the interaction with the ApoER2 receptor. This review discusses the current findings on the structure of Reelin and its binding to the ApoER2 and VLDLR receptors, and we discuss some areas where proteomics and structural biology can help understanding Reelin function in brain development and human health.
Introduction
Disruptions of the autosomal recessive Reelin gene were identified two decades ago to be responsible for the reeler phenotype in mice strains originated from Edinburgh and Orleans (D’Arcangelo et al., 1995; Hirotsune et al., 1995). The Edinburgh homozygous mutant reeler mouse displays a complete loss of transcription of the gene (D’Arcangelo et al., 1995) whereas the Orleans strain expresses a Reelin protein that lacks a C-terminal portion (Hirotsune et al., 1995; D’Arcangelo et al., 1997; de Bergeyck et al., 1997). Despite the different genomic abnormalities, both strains are characterized by specific neurological phenotypes including tremors, ataxia, cerebellar hypoplasia and malformation of cellular layers throughout the brain (Falconer, 1951; Angevine and Sidman, 1961; Caviness and Rakic, 1978; Pinto-Lord et al., 1982; Rakic and Caviness, 1995; Lambert de Rouvroit and Goffinet, 1998, and others). The involvement of Reelin in layer formation in brain cortical structures was extensively investigated (for an excellent review, see D’Arcangelo, 2014). It is now well established that during embryonic brain development, Reelin has a crucial role in controlling the radial migration of neurons, allowing them to reach their appropriate positions in laminated structures such as the cerebral cortex, the hippocampus or the cerebellum (Lambert de Rouvroit and Goffinet, 1998). Control of neuronal migration and layer formation is achieved by expression and secretion of Reelin by specific sub-types of cells, namely by Cajal-Retzius cells in marginal regions of the cerebral cortex and the hippocampus (D’Arcangelo et al., 1995; Ogawa et al., 1995; Del Río et al., 1997; Nakajima et al., 1997; Schiffmann et al., 1997; Alcantara et al., 1998), or by granule cell precursors localized in the external granule layer of the embryonic cerebellum (D’Arcangelo et al., 1995; Miyata et al., 1996; Alcantara et al., 1998). Additionally, small level of Reelin expression have been detected in deeper layers of the cerebral cortex (Yoshida et al., 2006; Uchida et al., 2009; Hirota et al., 2015). It is thought that secreted full length Reelin directs the migration of neurons in contact with these regions, whereas proteolytic fragments (see below), which diffuse towards deeper cortical layers, may target local neurons and initiate their polarization and their radial migration (Utsunomiya-Tate et al., 2000; Kubo et al., 2002; Jossin et al., 2007). Reelin was also shown to influence neurite formation in early postnatal brain (Del Río et al., 1997; Olson et al., 2006; Matsuki et al., 2010; Nichols and Olson, 2010) and to impact synapse formation and function in late postnatal and adult brain (Borrell et al., 1999; Liu et al., 2001; Rice et al., 2001; Qiu et al., 2006; Iafrati et al., 2014). At least some of these effects come into play through the association of Reelin with two well-known receptors of the low density lipoprotein receptor (LDLR) superfamily: the apolipoprotein E receptor 2 (ApoER2) and the very-low-density lipoprotein receptor (VLDLR) (D’Arcangelo et al., 1999; Hiesberger et al., 1999; Trommsdorff et al., 1999; Benhayon et al., 2003).
Following the initial observation that REELIN mRNA levels are reduced in patients with schizophrenia (Impagnatiello et al., 1998), several investigators reported a deficiency in Reelin expression in different groups of psychiatric subjects, including those with bipolar disorder (Knuesel, 2010). The reduction in Reelin expression occurs most likely through epigenetic mechanisms that affect promoter methylation (Veldic et al., 2004; Grayson et al., 2006) although evidence for genetic association between schizophrenia and REELIN polymorphisms also exists in patient subpopulations (Goldberger et al., 2005; Wedenoja et al., 2008). Furthermore, Reelin has been reported to suppress schizophreniform symptoms in mice (Ishii et al., 2015). In addition to schizophrenia, reduced expression and REELIN polymorphisms have been reported in some groups of autistic patients (De Rubeis et al., 2014).
This review discusses the architecture and three-dimensional structure of Reelin, highlighting the elements that are involved in the interaction with ApoER2 and VLDLR. We will discuss the proteolysis of Reelin and we will suggest areas of exploration that, in our opinion, will provide valuable information of the structural and functional mechanisms underlying the biological function of Reelin.
Structure of Reelin
Reelin is a ~440 kDa secreted glycoprotein (~386 kDa with ~18 putative N-linked glycosylation sites) expressed from a large genomic section (~450 kb spanned by 65 exons) located on chromosome 5 in mouse and 7 in humans. Mouse and human Reelin have ~94.2% and ~87.2% sequence identity at the amino acid and DNA levels, respectively (DeSilva et al., 1997). From the N- to the C-termini, Reelin is composed of a Reeler domain similar to the N-terminal domain of F-spondin, followed by a unique region named “H” (~300 amino acids), subdivided in three subdomains termed X, Y and Z (Ichihara et al., 2001) and eight Reelin-specific repeats followed by a highly basic region. Each Reelin repeat (RR) is ~350–390 amino-acid residues long, divided into two homologous sub-repeats (A and B) separated by an epidermal growth factor (EGF) domain of about 35 amino-acid residues (Figure 1). The eight RRs are structurally similar, with an average sequence identity in the range of 83.5–87.9% when comparing the same RR of Reelin homologs from 167 species. Interestingly, the amino acid identity of the eight RR in the same molecule is in the range of 36.4–39.7% (Manoharan et al., 2015), suggesting that albeit the identity is sufficient to maintain similar tertiary structure, these domains are likely to be functionally different (e.g., interact with different receptors).
Figure 1. Domain organization and structural model of Reelin in association with apolipoprotein E receptor 2 (ApoER2) or very-low-density lipoprotein receptor (VLDLR). Top diagram shows the domain organization of Reelin. Three in vivo proteolysis sites (white arrows) are represented on the top of the diagram, highlighting the N-terminal (N-ter.), Central, C-terminal (C-ter.) and the WC cleavage products. The Reelin repeats are numbered (1–8) and their sub-domain composition (subrepeats A and B separated by an epidermal growth factor (EGF)-like (E) domain) is marked. On the left side of RR1 the Reeler domain and the domains X, Y and Z (fragment “H”) are marked. The white box on the right side (C-terminally RR8) represents the conserved fragment of the CTR. The boundaries of each domain and RR are indicated on the bottom of the diagram and are identified by numbers corresponding to the mouse Reelin sequence (Uniprot : Q60841) and are adapted from Ichihara et al. (2001). Below the bar diagram, a three-dimensional model of Reelin (surface representation) was assembled using the established crystal structures of RR3 (yellow, PDB: 2DDU) and RR5–6 (orange, PDB: 2E26) and homology-models of each other RR and the X, Y and Z domains. The template used for the Reeler domain model was the N-terminal domain of F-spondin (PDB: 3COO). The homology models were built with the Swiss-model server1 and the RR models were positioned relatively to each other to best reproduce the inter-repeat interface observed in the crystal structure of RR5–6. The CTR is represented at the C-terminus of the Reelin model as a single-letter amino acid sequence. The basic residues are highlighted in blue, and the WC cleavage recognition sequence (RRRR) is green. Schematic representation of the LDLR-like receptor is shown on the lower right side of the figure. The domain organization of ApoER2 and VLDLR is similar to the architecture of LDLR, with the exception of an extra LDLR class A (LA) module not found in the latter (LA8*). Both ApoER2 and VLDLR receptors contain eight LA modules, three EGF-like domains, a unique β-propeller formed by YWTD (or LDLR class B) repeats separating EGF2 and EGF3. They also contain an O-linked glycosylation portion (stalk) upstream a single-pass transmembrane domain and a C-terminal cytoplasmic domain. No structure of large fragments of ApoER2 or VLDLR are currently available, thus the structure of the equivalent fragment of LDLR (PDB: 1N7D) was used to illustrate the binding with Reelin on the three-dimensional model (Rudenko et al., 2002). LDLR LA1 was overlaid with ApoER2 LA1 (red) in complex with RR5–6 (PDB: 3A7Q). The overall three-dimensional model uses the same color-code as the domain organization diagrams, for both partners. The crystal structure of RR5–6 in complex with ApoER2 LA1 is shown in more detail in the zoomed-in inset to highlight the folding of this Reelin fragment, and the location of the interfacing residue with ApoER2. The Reelin sub-repeats and EGF-like domain are distinguished by their color: A in light orange, B in dark orange and EGF in yellow. The Ca2+ ions characteristic to Reelin sub-repeats and the receptor LA module are represented as green spheres. A detailed view of the major interfacing residues is illustrated in the inset, showing the critical interaction pattern established by Reelin Lys2467 with ApoER2 Asp69, Asp71 and Asp67.
Although the overall structure of Reelin has never been reported, individual structures of selected RRs were solved by macromolecular crystallography. The crystal structure of RR3 (Nogi et al., 2006, PDB ID: 2DDU) revealed that each sub-repeat of Reelin is composed by 11 β-strands organized in two antiparallel β-sheets that are arranged in parallel, forming a jelly-roll folding similar to the carbohydrate-binding module (CBM) of other unrelated proteins, and to the “galactose-binding domain-like” superfamily. One of the features of a RR is a compact “horseshoe-like” conformation, where sub-repeats A and B make extensive interfacial contacts, burying ~1600 Å2 of solvent-accessible area, including a loop protruding from the concave side of sub-repeat A (Nogi et al., 2006). This loop bulges from the middle of the fifth strand (strand “H”) of the β-sheet at the concave side and is found in all aligned Reelin sub-repeats A. The EGF-like domain that separates the two sub-repeats in the primary structure lies on the lateral side of the tertiary arrangement where it interacts with both sub-repeats A and B. A stretch of ~14 amino-acids termed “bacterial neuraminidase repeat” (BNR) or “Asp-box” is found in all Reelin sub-repeats in close proximity to the EGF-like domain. This motif (X-X-S/T-X-D/N-X-G-X-X-W, where X can be any amino acid) has been found in a few other mammalian proteins such as Sialidase1–3 proteins (Gaskell et al., 1995) and forms a β-hairpin that seems to have a structural rather than a functional purpose (Copley et al., 2001).
The β-sheets of the sub-repeats are curved, creating a concave and a convex side of the jelly-roll shape where a Ca2+ ion is bound at the convex side of RR3B, but also in all four sub-repeats in the RR5–6 Reelin fragment (Yasui et al., 2007, PDB ID: 2E26). The importance of this bound Ca2+ is further emphasized by the finding of a similar calcium-binding site in other structurally related proteins, like in the CBM domains (Nogi et al., 2006) or the Cleaved Adhesin domain family (Ganuelas et al., 2013).1
Together with the crystal structure of RR3, single particle electron tomography was used to image the four-repeats-containing Reelin fragment RR3–6 (Nogi et al., 2006). In addition to the compactness of each individual RR, repeats RR3 through RR6 appeared to be in close contact with each other, leading to a roughly straight particle. This particle was solved as a flattened rod-shaped three-dimensional map, with a maximum dimension of approximately four times the longest dimension of a single repeat. The structural continuity between RRs was analyzed in further detail with the crystal structure of RR5–6 (Yasui et al., 2007). The two repeats were related to each other by an almost perfect translational symmetry, and the inter-repeat interface buried solvent-accessible area of ~1500 Å2, mainly composed by hydrophobic contacts, suggesting a stable intramolecular conformation of the two repeats.
In Vivo Proteolysis of Reelin
In vivo, proteolysis of the mature protein occurs, over time, at two positions, within RR3 but close to the interface with RR2, and between RR6 and RR7. By antibody mapping, the fragmentation pattern of Reelin predicts the generation of three major proteolytic fragments (the so-called N-terminal, central and C-terminal fragments). The N-terminal cleavage site has been determined to occur between Pro-1244 and Ala-1245 within RR3 (Koie et al., 2014). Consistently, Reelin-P1244D mutant became protease resistant and had a longer biological effect compared to wild type (WT) Reelin (Koie et al., 2014). The C-terminal cleavage site of WT Reelin, between RR6 and RR7 was also recently identified between Ala2688 and Asp2689 (2685RSPA/DAG2691) (Sato et al., 2016). A Reelin mutant, in which Asp2689 is replaced by Lys appears to be resistant to C-terminal cleavage when incubated with culture supernatant of cerebellar granular neurons. Finally, bioinformatics analysis of the C-terminal Reelin sequence indicates the presence of a Furin recognition proteolysis site [R-X-(R/K)-R] between residues 3452 and 3455 (3452RRRR3455/SLRRYP3461). The presence of this cleavage site and the release of the last six amino acids were confirmed experimentally and named WC (Within the C-Terminal Region [CTR]) site (Kohno et al., 2015). Although the exact function of this cleavage is currently unknown, sequence conservation among mammals suggests a critical function in the mammalian brain. Taken together, these data indicate that cleavage of Reelin may play a critical role in regulating the duration and range of Reelin signaling in the developing brain.
The Reelin Receptors
Reelin binds with similar affinity to cell surface receptors VLDLR and ApoER2, two members of the LDLR family. These receptors are differentially expressed in different organs, tissues, and cell types (Trommsdorff et al., 1999). Reelin binding to ApoER2/VLDLR receptors activates intracellular Src family kinases (SFKs), which in turn phosphorylate the adaptor protein Disabled-1 (Dab1) at specific tyrosine residues (Arnaud et al., 2003; Suetsugu et al., 2004). Although binding to Reelin triggers common signal transduction mechanisms, they mediate diverse biological functions (D’Arcangelo et al., 1999; Hiesberger et al., 1999; Benhayon et al., 2003).
Structurally, both receptors are composed of an extracellular domain of ~800 amino acids, followed by a single transmembrane and an intracellular domain (Figure 1). The architecture of both receptors is very close to the prototypical LDLR (Rudenko et al., 2002), with seven or eight “LDLR class A” (LA) domains followed by three EGF modules and a unique YWDT β-propeller domain inserted between EGF2 and EGF3 (Figure 1).
A variety of protein-protein interaction assays such as protein pull-down, surface plasmon resonance and isothermal titration calorimetry assays were used to evaluate and quantify the interaction of Reelin to either receptor (Andersen et al., 2003; Yasui et al., 2007, 2010). These experiments determined that RR3–6 contained the necessary binding elements to associate with ApoER2/VLDLR receptors (Jossin et al., 2004) and that the minimal binding cassette seems to be the RR5–6 fragment. On the receptor side, it was shown that the LA-containing regions of ApoER2 and VLDLR were necessary to bind RR5–6 (D’Arcangelo et al., 1997; Koch et al., 2002; Andersen et al., 2003). In particular, the first LA module (LA1) was necessary for the Reelin interaction providing a dissociation constant (KD) in the nanomolar range. Interestingly, according to the reported KD values, supplemental LA domains appeared to modulate the affinity towards RR5–6. Between the two receptors, ApoER2-LA1 appeared to have higher affinity to RR5–6 than VLDLR-LA1 (Andersen et al., 2003; Yasui et al., 2010).
The crystal structure of the [RR5–6:ApoER2-LA1] complex revealed that the LA1 module interacts essentially with RR6A, close to the RR5–6 inter-Repeat interface (Yasui et al., 2010). Therefore, the observed essential role of RR5 in solution for the receptor association is likely to be indirect. Additionally, the high affinity interaction contrasts with the small interface area (696 Å2) observed in the crystal structure, suggesting that other portions of Reelin or the receptor may contribute to the interaction. Indeed, a multivalent binding mode is usually observed for the known ligand interactions involving LA modules in the LDLR family (Blacklow, 2007). For example the Receptor-Associated Protein (RAP), an endoplasmic reticulum escort protein for LDLR-like proteins, is capable of binding LA pairs rather than single LA modules (Andersen et al., 2000, 2001; Fisher et al., 2006).
A Ca2+ ion, characteristically bound to LA modules, is found in the ApoER2-LA1 structure, providing important structural basis for the observed Ca2+-dependency of the Reelin-receptor association (D’Arcangelo et al., 1999; Andersen et al., 2003). However, this ion-dependency may also result from the Reelin-bound Ca2+ described above (Nogi et al., 2006). Overall, the interaction between RR5–6 and the ApoER-LA1 is in accord with the canonical mode of interaction between LA modules and their protein partners as described by Blacklow (2007). This interaction involves a lysine (equivalent to RR5–6 Lys2467) or an arginine in interaction with three LA aspartate residues that are involved in the Ca2+-coordination, e.g., Asp67, Asp69 and Asp71 in ApoER2-LA1. Additionally, an aromatic side chain (equivalent to LA1 Trp64) stacks the aliphatic groups of the lysine side chain for a proper positioning for the interaction with the aspartates. Interestingly, the two structures of RR5–6 alone (Yasui et al., 2007) or in complex with the LA1 module of ApoER2 (Yasui et al., 2010) were almost perfectly superimposable, indicating that the binding of the receptor did not induce major structural changes within the repeats and sub-repeats of the RR5–6 fragment (Figure 1).
The VLDLR and ApoER2 receptors appear to mediate at least some of the known functions of Reelin in the central nervous system; however, other receptors may be responsible for additional function in the brain or in peripheral organs. In fact, Reelin was also found to associate with EphB2 and EphB3 by co-immunoprecipitation of both endogenous proteins from brain lysates (Sentürk et al., 2011). Unlike lipoprotein receptors, EphB2 appears to bind the N-terminal region of Reelin. This region was also reported to bind other putative Reelin receptors such as the Cadherin-related neuronal receptor-1 or CNR1 and integrin α3β1 (Senzaki et al., 1999; Dulabon et al., 2000). However, the binding to these receptors have not been further confirmed and characterized.
Future Perspectives
A great deal of information is currently available on the structure and function of Reelin in the developing brain. Nevertheless, many questions remain unanswered. For example, Reelin/VLDLR or ApoER2 interaction occurs in the central region of Reelin but the N-terminal portion of Reelin also influences ApoER2 and VLDLR function. This is indicated by the inhibition of Reelin activity by the CR-50 antibody, which binds to an epitope located between residues 251 and 407 of Reelin (Del Río et al., 1997; D’Arcangelo et al., 1997, 1999; Miyata et al., 1997), presumably through inhibition of Reelin multimerization (Utsunomiya-Tate et al., 2000; Kubo et al., 2002). Interestingly, residue Cys2101, located in the central fragment of Reelin was recently shown to be involved in Reelin dimerization (Yasui et al., 2011), indicating that the multimerization of Reelin is complex. Moreover, the Reelin poly-basic 32-residue long CTR (Figure 1) appears to be functionally significant for the ApoER2 or VLDLR signaling pathway (Nakano et al., 2007; Kohno et al., 2009) and for the structure and positioning of neurons in the developing and the postnatal cerebral cortex (Kohno et al., 2015). This fragment is extremely conserved in mammals, birds and reptiles (Nakano et al., 2007) and seems to be important for the efficient secretion of Reelin (D’Arcangelo et al., 1997; de Bergeyck et al., 1997) by maintaining the structural integrity of RR8 (Kohno et al., 2009). Together, these studies highlight the importance of other parts of Reelin that, whilst not directly involved in the receptor interaction, contribute to its function. At the molecular and structural levels, further analyses are clearly needed to fully understand the implication of these parts of Reelin, as well as of the other RRs that have not been characterized so far. Furthermore, emerging investigations indicate that alternative cell surface receptors, such as the EphB2 and EphB3, likely interact with other parts of Reelin. Kohno et al. (2015) observed that the fragment RR7–8 that does not bind to the LDLR-like receptors is able to bind to neuronal cell membrane as long as it includes an intact CTR.
Final Considerations
It will be interesting to characterize the full-length Reelin structurally, alone, and bound to its canonical receptors. However, the large size, extensive N-linked glycosylation, multimerization, and potential intra-molecular flexibility, make this study difficult to complete using protein crystallography. A combination of lower resolution approaches, including small angle X-ray scattering (Rubio-Marrero et al., 2016) and cryo electron microscopy (EM; Zhou, 2008) are likely to be the methods of choice. Another fascinating element is the significance of the proteolysis of Reelin. The degradation pattern seems to be well established and it is currently thought to negatively modulate the function of Reelin. However, it is also possible that cleavage into various RR segments enable these smaller fragments to diffuse to more distant brain layers and to bind and activate currently unrecognized cell surface receptors. In either case, the dynamic regulation of these events is not well understood and it should be an area of intense research. A precise profiling of Reelin degradation over time will be necessary to understand Reelin function in health and disease. Outstanding work has been done to determine the N- and C-terminal cleavage sites, as well as the newly recognized WC site. However, it is likely that, in vivo, Reelin is further degraded into smaller fragments that can have currently unrecognized activities.
Finally, it was recently reported that full-length Reelin, but not its central fragment, is capable of activating Erk1/2 signaling, leading to increased p90RSK phosphorylation and the induction of immediate-early gene expression. Remarkably, because Erk1/2 activation is not mediated by the canonical signal transduction pathway, a non-canonical pathway that works during brain development must exist (Lee et al., 2014).
Author Contributions
All authors have contributed to the writing of the manuscript. All authors listed, have made substantial, direct and intellectual contribution to the work, and approved it for publication.
Conflict of Interest Statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Acknowledgments
This work was supported by NIMH RO1-MH092906, CAUT14APL028, and BRAIN EAGER MCB-1450895 to DC. We would like to apologize to the authors of many excellent articles that, for space considerations, were not included in this review.
Footnotes
References
Alcantara, S., Ruiz, M., D’Arcangelo, G., Ezan, F., de Lecea, L., Curran, T., et al. (1998). Regional and cellular patterns of reelin mRNA expression in the forebrain of the developing and adult mouse. J. Neurosci. 18, 7779–7799.
Andersen, O. M., Benhayon, D., Curran, T., and Willnow, T. E. (2003). Differential binding of ligands to the apolipoprotein E receptor 2. Biochemistry 42, 9355–9364. doi: 10.1021/bi034475p
Andersen, O. M., Christensen, L. L., Christensen, P. A., Sørensen, E. S., Jacobsen, C., Moestrup, S. K., et al. (2000). Identification of the minimal functional unit in the low density lipoprotein receptor-related protein for binding the receptor-associated protein (RAP). A conserved acidic residue in the complement-type repeats is important for recognition of RAP. J. Biol. Chem. 275, 21017–21024. doi: 10.1074/jbc.M000507200
Andersen, O. M., Schwarz, F. P., Eisenstein, E., Jacobsen, C., Moestrup, S. K., Etzerodt, M., et al. (2001). Dominant thermodynamic role of the third independent receptor binding site in the receptor-associated protein RAP. Biochemistry 40, 15408–15417. doi: 10.1021/bi0110692
Angevine, J. B., Jr., and Sidman, R. L. (1961). Autoradiographic study of cell migration during histogenesis of cerebral cortex in the mouse. Nature 192, 766–768. doi: 10.1038/192766b0
Arnaud, L., Ballif, B. A., Förster, E., and Cooper, J. A. (2003). Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. Curr. Biol. 13, 9–17. doi: 10.1016/s0960-9822(02)01397-0
Benhayon, D., Magdaleno, S., and Curran, T. (2003). Binding of purified Reelin to ApoER2 and VLDLR mediates tyrosine phosphorylation of disabled-1. Brain Res. Mol. Brain Res. 112, 33–45. doi: 10.1016/s0169-328x(03)00032-9
Blacklow, S. C. (2007). Versatility in ligand recognition by LDL receptor family proteins: advances and frontiers. Curr. Opin. Struct. Biol. 17, 419–426. doi: 10.1016/j.sbi.2007.08.017
Borrell, V., Del Río, J. A., Alcántara, S., Derer, M., Martínez, A., D’Arcangelo, G., et al. (1999). Reelin regulates the development and synaptogenesis of the layer-specific entorhino-hippocampal connections. J. Neurosci. 19, 1345–1358.
Caviness, V. S., Jr., and Rakic, P. (1978). Mechanisms of cortical development: a view from mutations in mice. Annu. Rev. Neurosci. 1, 297–326. doi: 10.1146/annurev.ne.01.030178.001501
Copley, R. R., Russell, R. B., and Ponting, C. P. (2001). Sialidase-like Asp-boxes: sequence-similar structures within different protein folds. Protein Sci. 10, 285–292. doi: 10.1110/ps.31901
D’Arcangelo, G. (2014). Reelin in the years: controlling neuronal migration and maturation in the mammalian brain. Adv. Neurosci. 2014:19. doi: 10.1155/2014/597395
D’Arcangelo, G., Homayouni, R., Keshvara, L., Rice, D. S., Sheldon, M., and Curran, T. (1999). Reelin is a ligand for lipoprotein receptors. Neuron 24, 471–479. doi: 10.1016/s0896-6273(00)80860-0
D’Arcangelo, G., Miao, G. G., Chen, S. C., Soares, H. D., Morgan, J. I., and Curran, T. (1995). A protein related to extracellular matrix proteins deleted in the mouse mutant reeler. Nature 374, 719–723. doi: 10.1038/374719a0
D’Arcangelo, G., Nakajima, K., Miyata, T., Ogawa, M., Mikoshiba, K., and Curran, T. (1997). Reelin is a secreted glycoprotein recognized by the CR-50 monoclonal antibody. J. Neurosci. 17, 23–31.
de Bergeyck, V., Nakajima, K., Lambert de Rouvroit, C., Naerhuyzen, B., Goffinet, A. M., Miyata, T., et al. (1997). A truncated Reelin protein is produced but not secreted in the ‘Orleans’ reeler mutation (Reln[rl-Orl]). Brain Res. Mol. Brain Res. 50, 85–90. doi: 10.1016/s0169-328x(97)00166-6
De Rubeis, S., He, X., Goldberg, A. P., Poultney, C. S., Samocha, K., Cicek, A. E., et al. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209–215. doi: 10.1038/nature13772
Del Río, J. A., Heimrich, B., Borrell, V., Förster, E., Drakew, A., Alcántara, S., et al. (1997). A role for Cajal-Retzius cells and reelin in the development of hippocampal connections. Nature 385, 70–74. doi: 10.1038/385070a0
DeSilva, U., D’Arcangelo, G., Braden, V. V., Chen, J., Miao, G. G., Curran, T., et al. (1997). The human reelin gene: isolation, sequencing and mapping on chromosome 7. Genome Res. 7, 157–164. doi: 10.1101/gr.7.2.157
Dulabon, L., Olson, E. C., Taglienti, M. G., Eisenhuth, S., McGrath, B., Walsh, C. A., et al. (2000). Reelin binds α3β1 integrin and inhibits neuronal migration. Neuron 27, 33–44. doi: 10.1016/s0896-6273(00)00007-6
Falconer, D. S. (1951). Two new mutants, ‘trembler’ and ‘reeler’, with neurological actions in the house mouse (Mus musculus L.). J. Genet. 50, 192–201. doi: 10.1007/bf02996215
Fisher, C., Beglova, N., and Blacklow, S. C. (2006). Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol. Cell 22, 277–283. doi: 10.1016/j.molcel.2006.02.021
Ganuelas, L. A., Li, N., Yun, P., Hunter, N., and Collyer, C. A. (2013). The lysine gingipain adhesin domains from Porphyromonas gingivalis interact with erythrocytes and albumin: structures correlate to function. Eur. J. Microbiol. Immunol. (Bp) 3, 152–162. doi: 10.1556/EuJMI.3.2013.3.2
Gaskell, A., Crennell, S., and Taylor, G. (1995). The three domains of a bacterial sialidase: a beta-propeller, an immunoglobulin module and a galactose-binding jelly-roll. Structure 3, 1197–1205. doi: 10.1016/s0969-2126(01)00255-6
Goldberger, C., Gourion, D., Leroy, S., Schürhoff, F., Bourdel, M. C., Leboyer, M., et al. (2005). Population-based and family-based association study of 5’UTR polymorphism of the reelin gene and schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 137B, 51–55. doi: 10.1002/ajmg.b.30191
Grayson, D. R., Chen, Y., Costa, E., Dong, E., Guidotti, A., Kundakovic, M., et al. (2006). The human reelin gene: transcription factors (+), repressors (-) and the methylation switch (+/–) in schizophrenia. Pharmacol. Ther. 111, 272–286. doi: 10.1016/j.pharmthera.2005.01.007
Hiesberger, T., Trommsdorff, M., Howell, B. W., Goffinet, A., Mumby, M. C., Cooper, J. A., et al. (1999). Direct binding of Reelin to VLDL receptor and ApoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation. Neuron 24, 481–489. doi: 10.1016/s0896-6273(00)80861-2
Hirota, Y., Kubo, K., Katayama, K., Honda, T., Fujino, T., Yamamoto, T. T., et al. (2015). Reelin receptors ApoER2 and VLDLR are expressed in distinct spatiotemporal patterns in developing mouse cerebral cortex. J. Comp. Neurol. 523, 463–478. doi: 10.1002/cne.23691
Hirotsune, S., Takahara, T., Sasaki, N., Hirose, K., Yoshiki, A., Ohashi, T., et al. (1995). The reeler gene encodes a protein with an EGF-like motif expressed by pioneer neurons. Nat. Genet. 10, 77–83. doi: 10.1016/0168-9525(95)90549-9
Iafrati, J., Orejarena, M. J., Lassalle, O., Bouamrane, L., Gonzalez-Campo, C., and Chavis, P. (2014). Reelin, an extracellular matrix protein linked to early onset psychiatric diseases, drives postnatal development of the prefrontal cortex via GluN2B-NMDARs and the mTOR pathway. Mol. Psychiatry 19, 417–426. doi: 10.1038/mp.2013.66
Ichihara, H., Jingami, H., and Toh, H. (2001). Three novel repetitive units of reelin. Brain Res. Mol. Brain Res. 97, 190–193. doi: 10.1016/s0169-328x(01)00307-2
Impagnatiello, F., Guidotti, A. R., Pesold, C., Dwivedi, Y., Caruncho, H., Pisu, M. G., et al. (1998). A decrease of reelin expression as a putative vulnerability factor in schizophrenia. Proc. Natl. Acad. Sci. U S A 95, 15718–15723. doi: 10.1073/pnas.95.26.15718
Ishii, K., Nagai, T., Hirota, Y., Noda, M., Nabeshima, T., Yamada, K., et al. (2015). Reelin has a preventive effect on phencyclidine-induced cognitive and sensory-motor gating deficits. Neurosci. Res. 96, 30–36. doi: 10.1016/j.neures.2014.12.013
Jossin, Y., Gui, L., and Goffinet, A. M. (2007). Processing of Reelin by embryonic neurons is important for function in tissue but not in dissociated cultured neurons. J. Neurosci. 27, 4243–4252. doi: 10.1523/JNEUROSCI.0023-07.2007
Jossin, Y., Ignatova, N., Hiesberger, T., Herz, J., Lambert de Rouvroit, C., and Goffinet, A. M. (2004). The central fragment of Reelin, generated by proteolytic processing in vivo, is critical to its function during cortical plate development. J. Neurosci. 24, 514–521. doi: 10.1523/JNEUROSCI.3408-03.2004
Knuesel, I. (2010). Reelin-mediated signaling in neuropsychiatric and neurodegenerative diseases. Prog. Neurobiol. 91, 257–274. doi: 10.1016/j.pneurobio.2010.04.002
Koch, S., Strasser, V., Hauser, C., Fasching, D., Brandes, C., Bajari, T. M., et al. (2002). A secreted soluble form of ApoE receptor 2 acts as a dominant-negative receptor and inhibits Reelin signaling. EMBO J. 21, 5996–6004. doi: 10.1093/emboj/cdf599
Kohno, T., Honda, T., Kubo, K., Nakano, Y., Tsuchiya, A., Murakami, T., et al. (2015). Importance of Reelin C-terminal region in the development and maintenance of the postnatal cerebral cortex and its regulation by specific proteolysis. J. Neurosci. 35, 4776–4787. doi: 10.1523/JNEUROSCI.4119-14.2015
Kohno, T., Nakano, Y., Kitoh, N., Yagi, H., Kato, K., Baba, A., et al. (2009). C-terminal region-dependent change of antibody-binding to the eighth Reelin repeat reflects the signaling activity of Reelin. J. Neurosci. Res. 87, 3043–3053. doi: 10.1002/jnr.22143
Koie, M., Okumura, K., Hisanaga, A., Kamei, T., Sasaki, K., Deng, M., et al. (2014). Cleavage within Reelin repeat 3 regulates the duration and range of the signaling activity of Reelin protein. J. Biol. Chem. 289, 12922–12930. doi: 10.1074/jbc.M113.536326
Kubo, K., Mikoshiba, K., and Nakajima, K. (2002). Secreted Reelin molecules form homodimers. Neurosci. Res. 43, 381–388. doi: 10.1016/s0168-0102(02)00068-8
Lambert de Rouvroit, C., and Goffinet, A. M. (1998). The reeler mouse as a model of brain development. Adv. Anat. Embryol. Cell Biol. 150, 1–106. doi: 10.1007/978-3-642-72257-8_1
Lee, G. H., Chhangawala, Z., von Daake, S., Savas, J. N., Yates, J. R. III, Comoletti, D., et al. (2014). Reelin induces Erk1/2 signaling in cortical neurons through a non-canonical pathway. J. Biol. Chem. 289, 20307–20317. doi: 10.1074/jbc.M114.576249
Liu, W. S., Pesold, C., Rodriguez, M. A., Carboni, G., Auta, J., Lacor, P., et al. (2001). Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse. Proc. Natl. Acad. Sci. U S A 98, 3477–3482. doi: 10.1073/pnas.051614698
Manoharan, M., Muhammad, S. A., and Sowdhamini, R. (2015). Sequence analysis and evolutionary studies of reelin proteins. Bioinform. Biol. Insights 9, 187–193. doi: 10.4137/BBI.S26530
Matsuki, T., Matthews, R. T., Cooper, J. A., van der Brug, M. P., Cookson, M. R., Hardy, J. A., et al. (2010). Reelin and stk25 have opposing roles in neuronal polarization and dendritic Golgi deployment. Cell 143, 826–836. doi: 10.1016/j.cell.2010.10.029
Miyata, T., Nakajima, K., Aruga, J., Takahashi, S., Ikenaka, K., Mikoshiba, K., et al. (1996). Distribution of a reeler gene-related antigen in the developing cerebellum: an immunohistochemical study with an allogeneic antibody CR-50 on normal and reeler mice. J. Comp. Neurol. 372, 215–228. doi: 10.1002/(SICI)1096-9861(19960819)372:2<215::AID-CNE5>3.0.CO;2-6
Miyata, T., Nakajima, K., Mikoshiba, K., and Ogawa, M. (1997). Regulation of Purkinje cell alignment by reelin as revealed with CR-50 antibody. J. Neurosci. 17, 3599–3609.
Nakajima, K., Mikoshiba, K., Miyata, T., Kudo, C., and Ogawa, M. (1997). Disruption of hippocampal development in vivo by CR-50 mAb against reelin. Proc. Natl. Acad. Sci. U S A 94, 8196–8201. doi: 10.1073/pnas.94.15.8196
Nakano, Y., Kohno, T., Hibi, T., Kohno, S., Baba, A., Mikoshiba, K., et al. (2007). The extremely conserved C-terminal region of Reelin is not necessary for secretion but is required for efficient activation of downstream signaling. J. Biol. Chem. 282, 20544–20552. doi: 10.1074/jbc.M702300200
Nichols, A. J., and Olson, E. C. (2010). Reelin promotes neuronal orientation and dendritogenesis during preplate splitting. Cereb. Cortex 20, 2213–2223. doi: 10.1093/cercor/bhp303
Nogi, T., Yasui, N., Hattori, M., Iwasaki, K., and Takagi, J. (2006). Structure of a signaling-competent reelin fragment revealed by X-ray crystallography and electron tomography. EMBO J. 25, 3675–3683. doi: 10.1038/sj.emboj.7601240
Ogawa, M., Miyata, T., Nakajima, K., Yagyu, K., Seike, M., Ikenaka, K., et al. (1995). The reeler gene-associated antigen on Cajal-Retzius neurons is a crucial molecule for laminar organization of cortical neurons. Neuron 14, 899–912. doi: 10.1016/0896-6273(95)90329-1
Olson, E. C., Kim, S., and Walsh, C. A. (2006). Impaired neuronal positioning and dendritogenesis in the neocortex after cell-autonomous Dab1 suppression. J. Neurosci. 26, 1767–1775. doi: 10.1523/JNEUROSCI.3000-05.2006
Pinto-Lord, M. C., Evrard, P., and Caviness, V. S., Jr. (1982). Obstructed neuronal migration along radial glial fibers in the neocortex of the reeler mouse: a Golgi-EM analysis. Brain Res. 256, 379–393. doi: 10.1016/0165-3806(82)90181-x
Qiu, S., Korwek, K. M., Pratt-Davis, A. R., Peters, M., Bergman, M. Y., and Weeber, E. J. (2006). Cognitive disruption and altered hippocampus synaptic function in Reelin haploinsufficient mice. Neurobiol. Learn. Mem. 85, 228–242. doi: 10.1016/j.nlm.2005.11.001
Rakic, P., and Caviness, V. S., Jr. (1995). Cortical development: view from neurological mutants two decades later. Neuron 14, 1101–1104. doi: 10.1016/0896-6273(95)90258-9
Rice, D. S., Nusinowitz, S., Azimi, A. M., Martínez, A., Soriano, E., and Curran, T. (2001). The reelin pathway modulates the structure and function of retinal synaptic circuitry. Neuron 31, 929–941. doi: 10.1016/s0896-6273(01)00436-6
Rubio-Marrero, E. N., Vincelli, G., Jeffries, C. M., Shaikh, T. R., Pakos, I., Ranaivoson, F. M., et al. (2016). Structural characterization of the extracellular domain of CASPR2 and insights into its association with the novel ligand Contactin1. J. Biol. Chem. 291, 5788–5802. doi: 10.1074/jbc.M115.705681
Rudenko, G., Henry, L., Henderson, K., Ichtchenko, K., Brown, M. S., Goldstein, J. L., et al. (2002). Structure of the LDL receptor extracellular domain at endosomal pH. Science 298, 2353–2358. doi: 10.1126/science.1078124
Sato, Y., Kobayashi, D., Kohno, T., Kidani, Y., Prox, J., Becker-Pauly, C., et al. (2016). Determination of cleavage site of Reelin between its sixth and seventh repeat and contribution of meprin metalloproteases to the cleavage. J. Biochem. 159, 305–312. doi: 10.1093/jb/mvv102
Schiffmann, S. N., Bernier, B., and Goffinet, A. M. (1997). Reelin mRNA expression during mouse brain development. Eur. J. Neurosci. 9, 1055–1071. doi: 10.1111/j.1460-9568.1997.tb01456.x
Sentürk, A., Pfennig, S., Weiss, A., Burk, K., and Acker-Palmer, A. (2011). Ephrin Bs are essential components of the Reelin pathway to regulate neuronal migration. Nature 472, 356–360. doi: 10.1038/nature09874
Senzaki, K., Ogawa, M., and Yagi, T. (1999). Proteins of the CNR family are multiple receptors for Reelin. Cell 99, 635–647. doi: 10.1016/s0092-8674(00)81552-4
Suetsugu, S., Tezuka, T., Morimura, T., Hattori, M., Mikoshiba, K., Yamamoto, T., et al. (2004). Regulation of actin cytoskeleton by mDab1 through N-WASP and ubiquitination of mDab1. Biochem. J. 384, 1–8. doi: 10.1042/bj20041103
Trommsdorff, M., Gotthardt, M., Hiesberger, T., Shelton, J., Stockinger, W., Nimpf, J., et al. (1999). Reeler/Disabled-like disruption of neuronal migration in knockout mice lacking the VLDL receptor and ApoE receptor 2. Cell 97, 689–701. doi: 10.1016/s0092-8674(00)80782-5
Uchida, T., Baba, A., Pérez-Martinez, F. J., Hibi, T., Miyata, T., Luque, J. M., et al. (2009). Downregulation of functional Reelin receptors in projection neurons implies that primary Reelin action occurs at early/premigratory stages. J. Neurosci. 29, 10653–10662. doi: 10.1523/jneurosci.0345-09.2009
Utsunomiya-Tate, N., Kubo, K., Tate, S., Kainosho, M., Katayama, E., Nakajima, K., et al. (2000). Reelin molecules assemble together to form a large protein complex, which is inhibited by the function-blocking CR-50 antibody. Proc. Natl. Acad. Sci. U S A 97, 9729–9734. doi: 10.1073/pnas.160272497
Veldic, M., Caruncho, H. J., Liu, W. S., Davis, J., Satta, R., Grayson, D. R., et al. (2004). DNA-methyltransferase 1 mRNA is selectively overexpressed in telencephalic GABAergic interneurons of schizophrenia brains. Proc. Natl. Acad. Sci. U S A 101, 348–353. doi: 10.1073/pnas.2637013100
Wedenoja, J., Loukola, A., Tuulio-Henriksson, A., Paunio, T., Ekelund, J., Silander, K., et al. (2008). Replication of linkage on chromosome 7q22 and association of the regional Reelin gene with working memory in schizophrenia families. Mol. Psychiatry 13, 673–684. doi: 10.1038/sj.mp.4002047
Yasui, N., Kitago, Y., Beppu, A., Kohno, T., Morishita, S., Gomi, H., et al. (2011). Functional importance of covalent homodimer of reelin protein linked via its central region. J. Biol. Chem. 286, 35247–35256. doi: 10.1074/jbc.M111.242719
Yasui, N., Nogi, T., Kitao, T., Nakano, Y., Hattori, M., and Takagi, J. (2007). Structure of a receptor-binding fragment of reelin and mutational analysis reveal a recognition mechanism similar to endocytic receptors. Proc. Natl. Acad. Sci. U S A 104, 9988–9993. doi: 10.1073/pnas.0700438104
Yasui, N., Nogi, T., and Takagi, J. (2010). Structural basis for specific recognition of reelin by its receptors. Structure 18, 320–331. doi: 10.1016/j.str.2010.01.010
Yoshida, M., Assimacopoulos, S., Jones, K. R., and Grove, E. A. (2006). Massive loss of Cajal-Retzius cells does not disrupt neocortical layer order. Development 133, 537–545. doi: 10.1242/dev.02209
Keywords: Reelin, ApoER2, VLDLR, brain development, cortical layers, structure-function
Citation: Ranaivoson FM, von Daake S and Comoletti D (2016) Structural Insights into Reelin Function: Present and Future. Front. Cell. Neurosci. 10:137. doi: 10.3389/fncel.2016.00137
Received: 01 March 2016; Accepted: 10 May 2016;
Published: 27 May 2016.
Edited by:
Laura Lossi, University of Turin, ItalyReviewed by:
Kazunori Nakajima, Keio University School of Medicine, JapanFilippo Sean Giorgi, University Hospital of Pisa, Italy
Copyright © 2016 Ranaivoson, von Daake and Comoletti. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution and reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Davide Comoletti, Y29tb2xlZGFAcndqbXMucnV0Z2Vycy5lZHU=